GXMC
STJ

Global X Management Company’s St Jude Medical STJ Stock Holding History

Global X Management Company’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,896
Closed -$312K – 1245
2016
Q4 		$312K Buy
3,896
+2,112
+118% +$168K 0.01% 514
2016
Q3 		$142K Buy
1,784
+1,092
+158% +$88.2K 0.01% 674
2016
Q2 		$54K Buy
+692
New +$49.3K ﹤0.01% 683

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Global X Management Company's STJ Position: Q1 2017 in Review

Global X Management Company sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,896 shares — an estimated $312K sold.

Global X Management Company first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $312K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Global X Management Company reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Global X Management Company sold 3,896 St Jude Medical shares in Q1 2017, an estimated $312K.
  • Global X Management Company first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Global X Management Company's St Jude Medical position peaked at $312K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Global X Management Company's 13F filing for Q1 2017, filed 12 May 2017.